Closing Figures Unveiled: InMed Pharmaceuticals Inc (INM) Drop -20.79, Closes at 4.00

Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.

InMed Pharmaceuticals Inc (NASDAQ: INM) closed the day trading at $4.00 down -20.79% from the previous closing price of $5.05. In other words, the price has decreased by -$20.79 from its previous closing price. On the day, 0.63 million shares were traded. INM stock price reached its highest trading level at $4.75 during the session, while it also had its lowest trading level at $3.96.

Ratios:

For a better understanding of INM, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.22 and its Current Ratio is at 5.07. In the meantime, Its Debt-to-Equity ratio is 0.13 whereas as Long-Term Debt/Eq ratio is at 0.07.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 31 ’24 when MANCINI ALEXANDRA DIANE JANET sold 240 shares for $0.18 per share. The transaction valued at 42 led to the insider holds 0 shares of the business.

HULL ANDREW bought 37,500 shares of INM for $14,625 on Feb 21 ’24. The Director now owns 38,258 shares after completing the transaction at $0.39 per share. On Feb 20 ’24, another insider, ADAMS ERIC A, who serves as the President & CEO of the company, bought 41,600 shares for $0.36 each. As a result, the insider paid 14,922 and bolstered with 43,959 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INM now has a Market Capitalization of 2896608 and an Enterprise Value of 51453576. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.58 while its Price-to-Book (P/B) ratio in mrq is 0.32. Its current Enterprise Value per Revenue stands at 11.191 whereas that against EBITDA is -6.501.

Stock Price History:

The Beta on a monthly basis for INM is 0.67, which has changed by -0.30055404 over the last 52 weeks, in comparison to a change of 0.24359846 over the same period for the S&P500. Over the past 52 weeks, INM has reached a high of $15.70, while it has fallen to a 52-week low of $2.41. The 50-Day Moving Average of the stock is -14.46%, while the 200-Day Moving Average is calculated to be -22.05%.

Shares Statistics:

Over the past 3-months, INM traded about 466.54K shares per day on average, while over the past 10 days, INM traded about 2644210 shares per day. A total of 0.67M shares are outstanding, with a floating share count of 0.17M. Insiders hold about 0.65% of the company’s shares, while institutions hold 125.25% stake in the company. Shares short for INM as of 1730332800 were 5776 with a Short Ratio of 0.02, compared to 1727654400 on 4658. Therefore, it implies a Short% of Shares Outstanding of 5776 and a Short% of Float of 0.8699999999999999.

Most Popular